Assignee
AVEXXIN AS
NO·19 granted patents·13 pending applications·47 citations·filing 2003–2021
Top patents by PatentIndex Score
32 records- 0187US11691959B2Anti-inflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compoundsAVEXXIN AS·Filed 2021·Granted Jul 4, 2023·1 cites·1 claims
- 0284US10259801B2Anti-inflammatory and antitumor 2-oxothiazoles ABD 2-oxothiophenes compoundsAVEXXIN AS·Filed 2017·Granted Apr 16, 2019·4 cites·7 claims
- 0384US10150781B22-oxothiatole compounds having activity as CPLA2 inhibitors for the treatment of inflammatory disorders and hyperproliferative disordersAVEXXIN AS·Filed 2015·Granted Dec 11, 2018·6 cites·1 claims
- 0483US10851114B22-oxothiatole compounds having activity as cPLA2 inhibitors for the treatment of inflammatory disorders and hyperproliferative disordersAVEXXIN AS·Filed 2018·Granted Dec 1, 2020·2 cites·2 claims
- 0581US10085952B2Dermatitis treatmentAVEXXIN AS·Filed 2013·Granted Oct 2, 2018·4 cites·15 claims
- 0680US10370344B22-oxothiazole compounds and method of using same for chronic inflammatory disordersAVEXXIN AS·Filed 2017·Granted Aug 6, 2019·4 cites·8 claims
- 0780US8865768B2Use of polyunsaturated ketones for the treatment of psoriasisAVEXXIN AS·Filed 2013·Granted Oct 21, 2014·4 cites·6 claims
- 0878US7687543B2Use of polyunsaturated ketones for the treatment of psoriasisAVEXXIN AS·Filed 2003·Granted Mar 30, 2010·10 cites·2 claims
- 0977US9187396B2Compositions and methods for the treatment of glomerulonephritisAVEXXIN AS·Filed 2014·Granted Nov 17, 2015·4 cites·3 claims
- 1076US11034666B2Anti-inflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compoundsAVEXXIN AS·Filed 2019·Granted Jun 15, 2021·1 cites·11 claims
- 1175US9375409B2Use of polyunsaturated ketones for the treatment of psoriasisAVEXXIN AS·Filed 2014·Granted Jun 28, 2016·2 cites·7 claims
- 1271US10085953B2Skin cancer treatmentAVEXXIN AS·Filed 2015·Granted Oct 2, 2018·3 cites·17 claims
- 1367US10758499B2Dermatitis treatmentAVEXXIN AS·Filed 2018·Granted Sep 1, 2020·0 cites·16 claims
- 1465US9682930B2Rheumatoid arthritis treatmentAVEXXIN AS·Filed 2013·Granted Jun 20, 2017·2 cites·8 claims
- 1563US2021101913A12-oxothiatole compounds having activity as cpla2 inhibitors for the treatment of inflammatory disorders and hyperproliferative disordersAVEXXIN AS·Filed 2020·Application pending·0 cites
- 1662US2019322620A1Process for the preparation of a polyunsaturated ketone compoundAVEXXIN AS·Filed 2019·Application pending·0 cites
- 1758US10183911B2Process for the preparation of a polyunsaturated ketone compoundAVEXXIN AS·Filed 2016·Granted Jan 22, 2019·0 cites·24 claims
- 1857US2015376161A1Antiiflammatory and antitumor 2-oxothiazoles abd 2-oxothiophenes compoundsAVEXXIN AS·Filed 2014·Application pending·0 cites
- 1956US11351127B2Pharmaceutical compositionAVEXXIN AS·Filed 2017·Granted Jun 7, 2022·0 cites·16 claims
- 2055US10093618B2Process for the preparation of a polyunsaturated ketone compoundAVEXXIN AS·Filed 2014·Granted Oct 9, 2018·0 cites·27 claims
- 2151US2022304985A1Combination therapy for proliferative conditionsAVEXXIN AS·Filed 2020·Application pending·0 cites
- 2248US11439625B2Combination therapy for proliferative diseasesAVEXXIN AS·Filed 2017·Granted Sep 13, 2022·0 cites·9 claims
- 2347US10953004B2Combination therapy for proliferative diseasesAVEXXIN AS·Filed 2017·Granted Mar 23, 2021·0 cites·6 claims
- 2443US2021361628A12-oxothiazole compositions for treatment of fibrotic diseaseAVEXXIN AS·Filed 2019·Application pending·0 cites
- 2538US2020000744A1Pharmaceutical compositionAVEXXIN AS·Filed 2017·Application pending·0 cites
- 2638US2020323793A1Combination therapy comprising a polyunsaturated ketone and a calcineurin inhibitorAVEXXIN AS·Filed 2017·Application pending·0 cites
- 2738US2019209585A1Combination therapy comprising a polyunsaturated ketone and a secosteroidAVEXXIN AS·Filed 2017·Application pending·0 cites
- 2838US2019216815A1Combination therapy comprising a polyunsaturated ketone and a folic acid partnerAVEXXIN AS·Filed 2017·Application pending·0 cites
- 2934US2019255023A1Combination therapy comprising a thiazole and a corticosteroid to treat skin conditionsAVEXXIN AS·Filed 2017·Application pending·0 cites
- 3034US2019275010A1Combination therapy comprising a thiazole and a secosteroid to treat skin conditionsAVEXXIN AS·Filed 2017·Application pending·0 cites
- 3133US2022257531A1Compositions and methods for treatment of a fibrotic diseaseAVEXXIN AS·Filed 2018·Application pending·0 cites
- 3232US2020330399A1Combination therapy comprising a polyunsaturated ketone and a corticosteroidAVEXXIN AS·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when AVEXXIN AS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →